Combinations comprising a selective cyclooxygenase-2 inhibitor
CA 2464309 C · Owner: Wood, Alexander Wallace · Inventors: Wood, Alexander Wallace; Lassota, Peter; Chen, Ying-Nan Pan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A combination therapy for treating patients suffering from pre-malignant colon lesions (e.g. polyps) and colon cancer as well as other malignancies, is , disclosed. The patient is treated concurrently with a cycloocygenase-2 inhibitor and at least one compound selected from the group consisting of a microtubule interfering agent, an epithelial growth factor receptor tyrosine protein kinase inhibitor and a vascular endothelial growth factor receptor tyrosine kinase inhibitor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 2002 and granted January 3, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 24, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.